BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 19893027)

  • 21. Identification of inguinofemoral lymph node metastases by methylation markers in vulvar cancer.
    Oonk MH; Eijsink JJ; Volders HH; Hollema H; Wisman GB; Schuuring E; van der Zee AG
    Gynecol Oncol; 2012 May; 125(2):352-7. PubMed ID: 22266550
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Prognostic factors for and pattern of lymph-node involvement in patients with operable cervical cancer.
    Widschwendter P; Janni W; Scholz C; De Gregorio A; De Gregorio N; Friedl TWP
    Arch Gynecol Obstet; 2019 Dec; 300(6):1709-1718. PubMed ID: 31696367
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Incidence and distribution pattern of pelvic and paraaortic lymph node metastasis in patients with Stages IB, IIA, and IIB cervical carcinoma treated with radical hysterectomy.
    Sakuragi N; Satoh C; Takeda N; Hareyama H; Takeda M; Yamamoto R; Fujimoto T; Oikawa M; Fujino T; Fujimoto S
    Cancer; 1999 Apr; 85(7):1547-54. PubMed ID: 10193945
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Loss of p53 and c-myc overrepresentation in stage T(2-3)N(1-3)M(0) prostate cancer are potential markers for cancer progression.
    Qian J; Hirasawa K; Bostwick DG; Bergstralh EJ; Slezak JM; Anderl KL; Borell TJ; Lieber MM; Jenkins RB
    Mod Pathol; 2002 Jan; 15(1):35-44. PubMed ID: 11796839
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Clinical value of pretreatment serum Cyfra 21-1, tissue polypeptide antigen, and squamous cell carcinoma antigen levels in patients with cervical cancer.
    Gaarenstroom KN; Bonfrer JM; Kenter GG; Korse CM; Hart AA; Trimbos JB; Helmerhorst TJ
    Cancer; 1995 Sep; 76(5):807-13. PubMed ID: 8625184
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Role of one-step nucleic acid amplification (OSNA) to detect sentinel lymph node low-volume metastasis in early-stage cervical cancer.
    Bizzarri N; Pedone Anchora L; Zannoni GF; Santoro A; Valente M; Inzani F; Gallotta V; Conte C; Chiantera V; Fanfani F; Fagotti A; Ferrandina G; Scambia G
    Int J Gynecol Cancer; 2020 Mar; 30(3):364-371. PubMed ID: 31980488
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Cyclin D1 amplification in tongue and cheek squamous cell carcinoma.
    Mahdey HM; Ramanathan A; Ismail SM; Abraham MT; Jamaluddin M; Zain RB
    Asian Pac J Cancer Prev; 2011; 12(9):2199-204. PubMed ID: 22296356
    [TBL] [Abstract][Full Text] [Related]  

  • 28. SCC-Ag, lymph node metastases and sentinel node procedure in early stage squamous cell cervical cancer.
    van de Lande J; Davelaar EM; von Mensdorff-Pouilly S; Water TJ; Berkhof J; van Baal WM; Kenemans P; Verheijen RH
    Gynecol Oncol; 2009 Jan; 112(1):119-25. PubMed ID: 19007978
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Differential diagnostic performance of magnetic resonance imaging in the detection of lymph node metastases according to the tumor size in early-stage cervical cancer patients.
    Hong KS; Ju W; Choi HJ; Kim JK; Kim MH; Cho KS
    Int J Gynecol Cancer; 2010 Jul; 20(5):841-6. PubMed ID: 20606532
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Postoperative nomogram for the prediction of disease-free survival in lymph node-negative stage I-IIA cervical cancer patients treated with radical hysterectomy.
    Gülseren V; Kocaer M; Çakır İ; Özdemir İA; Sancı M; Güngördük K
    J Obstet Gynaecol; 2020 Jul; 40(5):699-704. PubMed ID: 31607197
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Characterization of long non-coding RNA expression profiles in lymph node metastasis of early-stage cervical cancer.
    Shang C; Zhu W; Liu T; Wang W; Huang G; Huang J; Zhao P; Zhao Y; Yao S
    Oncol Rep; 2016 Jun; 35(6):3185-97. PubMed ID: 27035672
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Diagnostic performance of nanoparticle-enhanced magnetic resonance imaging in the diagnosis of lymph node metastases in patients with endometrial and cervical cancer.
    Rockall AG; Sohaib SA; Harisinghani MG; Babar SA; Singh N; Jeyarajah AR; Oram DH; Jacobs IJ; Shepherd JH; Reznek RH
    J Clin Oncol; 2005 Apr; 23(12):2813-21. PubMed ID: 15837995
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Sentinel lymphatic mapping among women with early-stage cervical cancer: A systematic review.
    Cheng-Yen Lai J; Lai KJ; Yi-Yung Yu E; Hung ST; Chu CY; Wang KL
    Taiwan J Obstet Gynecol; 2018 Oct; 57(5):636-643. PubMed ID: 30342642
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Tumor-to-stroma cd8
    Guo S; Chen P; Yang Y; Wei W; Pan Y; Zeng F; Fan L; Wang W
    J Cancer Res Clin Oncol; 2024 Feb; 150(2):93. PubMed ID: 38369672
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Prognostic value of genomic alterations in invasive cervical squamous cell carcinoma of clinical stage IB detected by comparative genomic hybridization.
    Dellas A; Torhorst J; Jiang F; Proffitt J; Schultheiss E; Holzgreve W; Sauter G; Mihatsch MJ; Moch H
    Cancer Res; 1999 Jul; 59(14):3475-9. PubMed ID: 10416613
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Nomogram for predicting para-aortic lymph node metastases in patients with cervical cancer.
    Wang W; Liu X; Meng Q; Zhang F; Hu K
    Arch Gynecol Obstet; 2018 Aug; 298(2):381-388. PubMed ID: 29943132
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Preoperative prognostic variables and the impact of postoperative adjuvant therapy on the outcomes of Stage IB or II cervical carcinoma patients with or without pelvic lymph node metastases: an analysis of 891 cases.
    Lai CH; Hong JH; Hsueh S; Ng KK; Chang TC; Tseng CJ; Chou HH; Huang KG
    Cancer; 1999 Apr; 85(7):1537-46. PubMed ID: 10193944
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Immunoreactivities of human nonmetastatic clone 23 and p53 products are disassociated and not good predictors of lymph node metastases in early-stage cervical cancer patients.
    Tee YT; Wang PH; Ko JL; Chen GD; Chang H; Lin LY
    Eur J Gynaecol Oncol; 2007; 28(1):18-22. PubMed ID: 17375700
    [TBL] [Abstract][Full Text] [Related]  

  • 39. LAMP3 expression correlated with poor clinical outcome in human ovarian cancer.
    Wang D; Cao X; Zhang Y; Liu Y; Yao C; Ge W; Xu Y
    Tumour Biol; 2017 Mar; 39(3):1010428317695014. PubMed ID: 28349821
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Accuracy of microRNAs as markers for the detection of neck lymph node metastases in patients with head and neck squamous cell carcinoma.
    de Carvalho AC; Scapulatempo-Neto C; Maia DC; Evangelista AF; Morini MA; Carvalho AL; Vettore AL
    BMC Med; 2015 May; 13():108. PubMed ID: 25956054
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.